MediGuide, MySpecialistMD Announce New Partnership
MediGuide International, MySpecialistMD partner to provide an unprecedented, all-inclusive medical support experience for members.
MediGuide International, a medical second opinion (MSO) organization with nearly 20 years of experience in domestic and international service, recently announced a partnership with MySpecialistMD (MSMD), a first-class provider of specialty and sub-specialty telemedicine care worldwide.
“Together, MediGuide and MSMD now provide their member base the opportunity to access real time medical support for acute and chronic conditions via a virtual MD visit, in addition to an in-depth and interdisciplinary MSO”, says MediGuide’s CEO Paul Vermeulen.
“Globally, patients can now access cutting edge medical information anytime, anywhere and with ease, changing the way the world gains access to healthcare information. Moreover, the highest level of clinical care will continue to be delivered, via a much more efficient, cost effective and personal vehicle”, per John S. Martin, Executive Director of MySpecialistMD.
What makes this partnership most exciting are the tremendous additional benefits MediGuide and MSMD can now offer their new and existing customer and membership base including:
Enables easy access to a network of board certified specialists at a minimal cost and in a timely fashion.
FOR INSURANCE COMPANIES:
Reduce healthcare costs by avoiding unnecessary hospitalizations and readmissions
Reduce healthcare costs by ensuring members have the correct diagnosis and treatment plan
Prevent unnecessary and expensive ER visits
MediGuide International currently services millions of member lives in 40+ countries across the globe with its MSO services. This allows members access to the best medical information available for their specific condition. The MediGuide experience is like no other MSO in its space, since its process allows for a holistic review of medical information by a team of physicians versus a single ‘expert’ physician review. In addition, MediGuide International has launched its LifeLink Insurance program, supported globally by SwissRe. Recently, MediGuide launched a new service for members seeking medical treatment abroad without insurance: Navigator. Insurance companies dealing with MediGuide will be able to either insure the new program or offer it on an access basis to its insured.
MySpecialistMD was founded in 2015 as a multi-specialty telemedicine practice with a mission of changing the way medical care is delivered across the world by providing outstanding specialty and sub-specialty telemedicine care worldwide. With a network of the world’s best primary care, specialty care, and subspecialty care physicians, and utilizing a world-class technology platform, MSMD delivers expert telemedicine services in almost any field of medicine, clinical care or diagnostics. MSMD works with a diverse client base and provides clinical services in a variety of settings. MSMD’s primary goal centers around providing access to specialty care in settings where it would otherwise be unavailable, improving management of both common and rare diseases, and optimizing outcomes while providing cost effective solutions for patients with chronic diseases.
MSMD has created a virtual hospital capable of extending the reach of primary and specialty care and shattering the barriers of traditional medicine, by utilizing a cloud based system to provide patients with immediate, cost effective access to expert medical care. A simple and user-friendly process allows the user to have a MD visit from anywhere in the world via a variety of desktop and handheld devices. MD specialists can assess, diagnose, prescribe, and network with local providers via the online visit, with no travel time or hospital systems to navigate. MSMD leverages the most advanced telemedicine technology to integrate with clients’ medical platforms, optimizing collaboration among care providers and ensuring optimal medical outcomes.
MediGuide and MySpecialistMD are very excited about the journey ahead in 2017 and beyond.